Tong Nuo Kang (同诺康)
China, China
Synnocare Pharmaceutical (南京同诺康医药科技有限公司) is a Chinese biotechnology and pharmaceutical company focused on developing innovative small-molecule drugs to address unmet clinical needs, particularly in areas such as cancer, autoimmune disorders, and central nervous system (CNS) diseases. The company integrates artificial intelligence and multi-omics technologies into its drug discovery and development process, spanning target identification, molecule design, and clinical trial planning. Its business model centers on creating original drugs with global IP rights, with potential commercialization through partnerships, licensing, and direct product development.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.synnocare.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Tong Nuo Kang (同诺康)?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now